je.st
news
Tag: endo
Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission ...
2014-12-24 16:54:20| Biotech - Topix.net
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc , and BioDelivery Sciences International, Inc. announced today that they have submitted a New Drug Application for Buprenorphine HCl Buccal Film to the U.S. Food and Drug Administration . Buprenorphine HCl Buccal Film is under development for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Tags: sciences
submission
announce
pharmaceuticals
Endo to pay $25M for nasal testosterone replacement therapy
2014-11-25 00:20:24| Biotech - Topix.net
Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million. Natesto is the only testosterone nasal gel approved by the Food and Drug Administration as a replacement therapy for adult males with hypogonadism - a condition where sex glands produce little or no sex hormones.
Tags: pay
therapy
replacement
25m
Endo Intl to buy Auxilium in deal worth $2.6B
2014-10-10 12:31:51| Biotech - Topix.net
Ireland's Endo International is planning to buy Auxilium Pharmaceuticals in a sweetened cash-and-stock deal valued at $2.6 billion a few weeks after Auxilium rejected a lower bid. The Auxilium board embraced the latest offer but its shareholders get to vote on it.
Endo Intl to buy Auxilium in deal worth $2.6B
2014-10-09 17:23:41| Biotech - Topix.net
Ireland's Endo International is planning to buy Auxilium Pharmaceuticals in a sweetened cash-and-stock deal valued at $2.6 billion a few weeks after Auxilium rejected a lower bid. The Auxilium board embraced the latest offer but its shareholders get to vote on it.
Endo Int'l makes $1.4B offer for Auxilium Pharma
2014-09-17 02:31:59| Biotech - Topix.net
Endo International PLC says it is making an unsolicited offer for Auxilium Pharmaceuticals that values Auxilium at $28.10 per share. The deal is worth $1.41 billion in cash and stock, based on Auxilium's shares outstanding.